David Capper

Prof. David Capper is a professor of molecular neuropathology at the Charité and a group leader of the German Cancer Consortium, partner site Berlin. His research focuses on the pathology and genetics of tumors of the central nervous system with a special focus on the development of specific diagnostic markers ("mutation-specific monoclonal antibodies") and classification of brain tumors by genome-wide analysis of DNA methylation patterns. In addition, he headed the central pathology for several national and international studies (e.g. LOGGIC registry study (ongoing), INFORM registry study, MNP2.0 study). He was awarded with several national and international awards (e.g. Innovation prize of the Deutsche Hochschulmedizin e.V. in 2018; Matthew T Moore Lecturer of the American Association of Neuropathologist in 2020) and is lead author of several chapters of the upcoming CNS WHO classification.